Hormonal therapy is associated with a lower prevalence of breast arterial calcification on mammography.
Publication/Presentation Date
6-20-2007
Abstract
OBJECTIVE: To bring further understanding to the relationship between hormonal therapy (HT) and breast arterial calcification (BAC).
METHODS: Of women arriving for breast cancer screening mammography, 1995 consented to complete a survey and have their mammograms analyzed for the presence of BAC. The survey assessed HT use and major risk factors for CAD.
RESULTS: Of the 1919 women with complete data, there were 268 with BAC (14%). When categorized into three age groups, BAC was present in 40.7% of the women > or =65, 10.9% of those 55-64 and 3.0% of thoseor =65 year-old group showed a nearly 50%-point lower prevalence of BAC among HT users compared with women who were not on HT (25.8% versus 74.2%, respectively, p=0.006). With age included as a continuous variable, past use of HT was significantly associated with a lower prevalence of BAC (p
CONCLUSIONS: Well-established cardiovascular risk factors (diabetes, stroke, and age) appear to be associated with a significantly higher incidence of BAC, while HT during the menopausal years appears to be associated with a significantly lower prevalence of BAC.
Volume
57
Issue
2
First Page
154
Last Page
160
ISSN
0378-5122
Published In/Presented At
Schnatz, P. F., Rotter, M. A., Hadley, S., Currier, A. A., & O'Sullivan, D. M. (2007). Hormonal therapy is associated with a lower prevalence of breast arterial calcification on mammography. Maturitas, 57(2), 154–160. https://doi.org/10.1016/j.maturitas.2006.12.002
Disciplines
Medicine and Health Sciences
PubMedID
17289309
Department(s)
Department of Obstetrics and Gynecology
Document Type
Article